CDKN2A and acute lymphoblastic leukemia: Irrespective of the mutational mechanisms involved in these PTEN mutations, we conclude that in STIL-TAL1 ALL there is a strong selective pressure for these genetic lesions, most likely related to epistasis or a strong functional complementarity between PTEN inactivation/loss, STIL-TAL1 fusion and CDKN2A loss.